References
- Keks N A, Kulkarni J, Copolov D L. Treatment of schizophrenia. The Medical Journal of Australia 1989; 151: 467
- Kane J M, McGlashan T H. Treatment of schizophrenia. The Lancet 1995; 345: 25
- Kane J, Honigfeld G, Singer J, Meltzer H. The Clozaril Collaborative Study Group. Clozapine for the treatment of the resistant schizophrenic: a double blind comparison vs. chlorpromazine/benztropine. Archives of General Psychiatry 1988; 45: 789–796
- Marder S R, Meibach R C. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 1994; 151: 825–835
- Marder S R, Davis J M, Chouinard G. The effects of Risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry 1997; 58: 538–546
- Tollefson G D, Beasley C M, Tran P V, et al. Olanzapine vs. haloperidol in the treatment of schizophrenia and schizo-affective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 1997; 154: 457–465
- Tollefson G D, Sanger T M. Negative symptoms: a path analytical approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. American Journal of Psychiatry 1997; 154: 46–474
- Parker G, Lambert T, McGrath J, McGorry P, Tiller J. Neuroleptic management of schizophrenia: a survey and commentary on Australian psychiatric practice. Australian and New Zealand Journal of Psychiatry 1998; 32: 50–58
- Galletly C. Prescribing of psychotropic drugs in an acute inpatient unit. Australian and New Zealand Journal of Psychiatry 1999; 33: 281–282
- Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association, Washington, DC 1994
- Smith R C, Strizich M, Klass D. Drug history and tardive dyskinesia. American Journal of Psychiatry 1978; 135: 1402–1403
- Kane J M, Lieberman J A. Adverse effects of psychotropic drugs. Guilford, New York 1992.
- Luchins D J, Klass D, Hanrahan P, Malan R, Harris J. Alteration in the recommended dosing schedule for risperi-done. American Journal of Psychiatry 1998; 155: 365–366
- Keks N. Schizophrenia. Australian Journal of Hospital Pharmacy 1996; 26: 93–96
- Johnstone E C, Crow T J, Frith C D, Owens D G. The Northwick Park ‘functional’ psychosis study: diagnosis and treatment response. Lancet 1988; 2: 119–126
- American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia. American Journal of Psychiatry 1997; 154, (Suppl.)